Format

Send to

Choose Destination
See comment in PubMed Commons below
Indian Pacing Electrophysiol J. 2005 Apr 1;5(2):72-5.

Role of implantable cardioverter defibrillators in the treatment of hypertrophic cardiomyopathy.

Abstract

Hypertrophic cardiomyopathy (HCM) is an important cardiovascular disease with sudden cardiac death as the most devastating presentation. Implantable cardioverter defibrillators (ICD) are the optimal therapy for prevention of sudden death from ventricular tachycardia or fibrillation of any cause. While there is no controversy with implanting ICDs in patients who have already survived a cardiac arrest, identifying high-risk patients for primary prevention in this disease remains a challenge. Implanting ICDs in patients with HCM is an important clinical consideration since many individuals could achieve normal or near-normal lifespans with this protection.

PMID:
16943946
PMCID:
PMC1513528
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for PubMed Central
    Loading ...
    Support Center